Cargando…
The Effect of Aspirin Use on Incident Hepatocellular Carcinoma—An Updated Systematic Review and Meta-Analysis
SIMPLE SUMMARY: Aspirin has been observed to reduce the risk of developing hepatocellular carcinoma (HCC). This review pooled together the results of all available published studies and found that aspirin reduces the risk of HCC by around 30%. In patients with cirrhosis, this effect was not seen and...
Autores principales: | Abdelmalak, Jonathan, Tan, Natassia, Con, Danny, Eslick, Guy, Majeed, Ammar, Kemp, William, Roberts, Stuart K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341252/ https://www.ncbi.nlm.nih.gov/pubmed/37444628 http://dx.doi.org/10.3390/cancers15133518 |
Ejemplares similares
-
Current Therapeutics in Primary Sclerosing Cholangitis
por: Tan, Natassia, et al.
Publicado: (2023) -
TSH receptor autoantibody levels post-total thyroidectomy in Graves’ ophthalmopathy: a meta-analysis
por: Anees, Arsalan, et al.
Publicado: (2023) -
Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis
por: Yan, Lun-Jie, et al.
Publicado: (2022) -
Aspirin might reduce the incidence of breast cancer: An updated meta-analysis of 38 observational studies
por: Cao, Yueqing, et al.
Publicado: (2020) -
Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma
por: Zhou, Xueliang, et al.
Publicado: (2022)